Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission
批准号:
10579176
负责人:
Jason Randolph Andrews
金额:
$15.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-11 至 2024-02-29
关键词:
AddressAerosolsAlgorithmsBiological AssayBloodBrazilCalibrationCaringCause of DeathCharacteristicsClinicalCollaborationsCommunicable DiseasesCommunitiesCoughingCountryDataDevelopmentDiagnosisDiagnosticDiseaseDisparityEarly DiagnosisEarly treatmentEffectiveness of InterventionsEnvironmentEpidemicExhalationGene ExpressionGene Expression ProfileGene Expression ProfilingGeneral PopulationGoalsHIV SeronegativityHealthImprisonmentIncidenceIndividualInfectionInterventionJointsKnowledgeMasksMass ScreeningMeasuresMedicalMethodsModalityModelingMycobacterium tuberculosisPopulationPrevalencePrisonerPrisonsRecommendationReference StandardsResearchResearch InfrastructureRoentgen RaysRoleSamplingSputumSustainable DevelopmentSymptomsSystemTestingTimeTuberculosisTuberculosis diagnosisWhole Bloodcase findingcost effectivecost effectivenessdesigndiagnostic screeningdiagnostic strategyeffective therapyepidemiologic datagenetic signaturegenomic datamathematical modelmolecular diagnosticsnovelnovel diagnosticsnovel strategiespoint of carepreventscreeningsymptom treatmenttooltransmission process
中文摘要
项目摘要
结核病仍然是全世界传染病导致死亡的主要原因,
尽管有效的治疗方法广泛存在。两大科学知识
差距限制了我们有效应对这一流行病的能力:1)了解
在人群中传播感染的个人的特征;以及2)
确定在这些个体的疾病过程的早期诊断这些个体的有效方法
以防止持续传播。我们和其他人的初步研究
这表明,在任何给定的时间,在人口中,相当大的比例,
微生物学确诊的结核病患者很少或没有典型的
症状这种状态被称为“亚临床结核病”。多大比例的
病例是亚临床的,这些个体的传染性如何,以及
对亚临床结核病在人群中的传播了解甚少。这
该提案利用了我们在中西部监狱的独特研究基础设施
巴西将评估新工具,包括一次性口罩,以捕捉呼出的气体
生物气溶胶,用于早期发现无症状个体的结核病。我们将测试
以下假设:1)没有症状的结核病患者
平均至少有50%的感染性为那些有症状,并作出同样的贡献,
总体传播; 2)面罩气溶胶采样将比痰液更有效
在很少或没有症状的个体中进行结核病诊断测试; 3)每年两次
针对亚临床结核病的诊断的大规模筛查将是成本-
在监狱里有效。总的来说,这个项目将解决以下基本问题:
结核病传播,同时测试控制结核病的实用方法,
高负荷设置。
英文摘要
Project Summary
Tuberculosis remains the leading cause of death by an infectious disease worldwide,
despite the widespread availability of effective therapy. Two major scientific knowledge
gaps constrain our ability to effectively respond this epidemic: 1) understanding
characteristics of individuals who are transmitting infection within the population; and 2)
identifying efficient means of diagnosing these individuals early in their course of disease
to prevent ongoing transmission. Our preliminary research and that of others has
demonstrated that, for any given time in a population, a substantial proportion of
individuals with microbiologically confirmed tuberculosis have few or no classical
symptoms. This state has been described as “subclinical tuberculosis”. What fraction of
cases are subclinical, how infectious these individuals are, and the total contribution of
subclinical tuberculosis towards transmission in the population is poorly understood. This
proposal leverages our unique research infrastructure in prisons in Central-Western
Brazil to evaluate novel tools, including a disposable mask to capture exhaled
bioaerosols, for early detection of tuberculosis in asymptomatic individuals. We will test
the following hypotheses: 1) individuals with tuberculosis who lack symptoms are on
average at least 50% as infectious as those with symptoms, and contribute equally to
overall transmission; 2) mask aerosol sampling will be more effective than sputum
testing for tuberculosis diagnosis in individuals with few or no symptoms; 3) biannual
mass screening with diagnostics targeted at subclinical tuberculosis would be cost-
effective in prisons. Overall, this project will address fundamental questions about
tuberculosis transmission, while testing practical approaches to control tuberculosis in
high burden settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Point-of-care pharmacogenomic testing to optimize isoniazid dosing for tuberculosis prevention
-
批准号:10709589
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2022
-
负责人:Jason Randolph Andrews
-
依托单位:
Point-of-care pharmacogenomic testing to optimize isoniazid dosing for tuberculosis prevention
-
批准号:10537650
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2022
-
负责人:Jason Randolph Andrews
-
依托单位:
Evaluation of a point-of-care immunochromatographic assay for enteric fever
-
批准号:10392476
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2021
-
负责人:Jason Randolph Andrews
-
依托单位:
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission
-
批准号:10362565
-
项目类别:
-
资助金额:$15.07万
-
财政年份:2020
-
负责人:Jason Randolph Andrews
-
依托单位:
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission
-
批准号:9889831
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2020
-
负责人:Jason Randolph Andrews
-
依托单位:
Strategies for tuberculosis control in prisons
-
批准号:10607550
-
项目类别:
-
资助金额:$63.77万
-
财政年份:2017
-
负责人:Jason Randolph Andrews
-
依托单位:
Congregate air sampling for population-based detection of tuberculosis
-
批准号:9167046
-
项目类别:
-
资助金额:$197.09万
-
财政年份:2016
-
负责人:Jason Randolph Andrews
-
依托单位:
Network Models for Evaluating HIV-associated MDR TB transmission and control
-
批准号:8724335
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2013
-
负责人:Jason Randolph Andrews
-
依托单位:
Network Models for Evaluating HIV-associated MDR TB transmission and control
-
批准号:9100638
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2013
-
负责人:Jason Randolph Andrews
-
依托单位:
Network Models for Evaluating HIV-associated MDR TB transmission and control
-
批准号:8466080
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:Jason Randolph Andrews
-
依托单位:
Network Models for Evaluating HIV-associated MDR TB transmission and control
-
批准号:8798824
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2013
-
负责人:Jason Randolph Andrews
-
依托单位:
海外基金